A Randomized Control Trial of Narrative Exposure Therapy Versus Treatment as Usual in the Therapy of Borderline Personality Disorder
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Posttraumatic Stress Disorders
- Sponsor
- Zentrum für Integrative Psychiatrie
- Enrollment
- 80
- Locations
- 1
- Primary Endpoint
- Clinician-Administered PTSD Scale (CAPS)
- Last Updated
- 16 years ago
Overview
Brief Summary
Definition of the efficacy of NET compared with "treatment as usual" in the treatment of patients with complex traumatic disease (borderline personality disorder (BPD) and posttraumatic stress disorder (PTSD)) as assessed by structured clinical interviews. Furthermore, to evaluate the sleep, cortisol level and epigenetic differences in the process of the specific therapy compared to treatment as usual.
Detailed Description
Experimental intervention: Narrative Exposure Therapy (NET), an evidence-based trauma-focussed treatment, suitable for survivors of prolonged and repeated exposure to traumatic stress and childhood adversity. Control intervention: Treatment as usual. Follow-up per patient: 3 follow-up assessments- 4 weeks, 6 months,12 months and 24 months after end of experimental/ control intervention Duration of intervention per patient: Both treatment types will be conducted for 10-14 sessions of 60-90 min in length. Additionally 5 sleep laboratory investigations (1 pre- and 4 post- intervention (4 weeks, 6 months, 12 months, 24 months after treatment)) will be carried out. Additionally the cortisol level in the hair and epigenetic markers will be recorded. The estimated observation time is 2 years.
Investigators
Eligibility Criteria
Inclusion Criteria
- •DSM-IV -TR Diagnosis axis II: borderline personality disorder; axis I: posttraumatic stress disorder
- •stable medication
- •age 18-45 years, gender female
- •legal competence
- •sufficient cognitive function
- •sufficient knowledge of the German or English language
Exclusion Criteria
- •Known severe internal, neurological, musculoskeletal, endocrinological or sleep disorders with organic origin (clinical examination during the screening visit, judged by the investigator)
- •gravidity (positive ß-HCG test)
- •continuing and not interruptible exposure to sexual or physical abuse
- •acute suicidal tendency
- •positive drug-screening in urine toxicology test
Outcomes
Primary Outcomes
Clinician-Administered PTSD Scale (CAPS)
Time Frame: 0 - 1 - 6 - 12 - 24 month
Secondary Outcomes
- Borderline symptom checklist 23 (BSL)(0 - 1 - 6 - 12 - 24)